

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.77581239 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.77581239 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.61115050 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.61115050 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.09783348 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.82812504 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65000829 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.50489167 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.50368076 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.50368076 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.50368076 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.48237704 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 5.39561552 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.38779593 |
| 15 | cysteine metabolic process (GO:0006534) | 5.26109517 |
| 16 | urea metabolic process (GO:0019627) | 5.21434396 |
| 17 | urea cycle (GO:0000050) | 5.21434396 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.17499211 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.17445443 |
| 20 | exogenous drug catabolic process (GO:0042738) | 5.11379318 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.07684139 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06013266 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.03153942 |
| 24 | protein carboxylation (GO:0018214) | 4.99894852 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.99894852 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.88732465 |
| 27 | lysine catabolic process (GO:0006554) | 4.87287367 |
| 28 | lysine metabolic process (GO:0006553) | 4.87287367 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.80859100 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.78869383 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.74489358 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.65398118 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.64881463 |
| 34 | regulation of complement activation (GO:0030449) | 4.61913774 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 4.60780805 |
| 36 | bile acid metabolic process (GO:0008206) | 4.60372874 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.59976454 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.42113132 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.41239706 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.33109060 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.33109060 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.32678683 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.32678683 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32678683 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.31754940 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.30513328 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.30438040 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.21817783 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.21647572 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.21647572 |
| 51 | phospholipid efflux (GO:0033700) | 4.15518848 |
| 52 | glycine metabolic process (GO:0006544) | 4.14586635 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.11159083 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 4.03678140 |
| 55 | serine family amino acid metabolic process (GO:0009069) | 4.01276928 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 3.96912747 |
| 57 | * ethanol metabolic process (GO:0006067) | 3.95591335 |
| 58 | benzene-containing compound metabolic process (GO:0042537) | 3.91000430 |
| 59 | bile acid and bile salt transport (GO:0015721) | 3.89706815 |
| 60 | glutamate metabolic process (GO:0006536) | 3.87938468 |
| 61 | cellular glucuronidation (GO:0052695) | 3.87697536 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.87259599 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 3.87255697 |
| 64 | drug catabolic process (GO:0042737) | 3.83869946 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 3.80605855 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.80081189 |
| 67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79685726 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.79641003 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 3.77006551 |
| 70 | cholesterol efflux (GO:0033344) | 3.76336948 |
| 71 | acetyl-CoA metabolic process (GO:0006084) | 3.75594211 |
| 72 | fatty acid beta-oxidation (GO:0006635) | 3.74431342 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.72899167 |
| 74 | valine metabolic process (GO:0006573) | 3.72848140 |
| 75 | omega-hydroxylase P450 pathway (GO:0097267) | 3.71687440 |
| 76 | fatty acid oxidation (GO:0019395) | 3.70530081 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.69180060 |
| 78 | phospholipid homeostasis (GO:0055091) | 3.67991870 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67853139 |
| 80 | amine catabolic process (GO:0009310) | 3.67638180 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.67638180 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.65664424 |
| 83 | organic acid catabolic process (GO:0016054) | 3.65664424 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.64306814 |
| 85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.63379415 |
| 86 | carnitine metabolic process (GO:0009437) | 3.63355673 |
| 87 | lipid oxidation (GO:0034440) | 3.63212818 |
| 88 | drug metabolic process (GO:0017144) | 3.59509784 |
| 89 | arginine metabolic process (GO:0006525) | 3.58719466 |
| 90 | fibrinolysis (GO:0042730) | 3.58524409 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58137715 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58137715 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.56532826 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.55242112 |
| 95 | ketone body metabolic process (GO:1902224) | 3.55041193 |
| 96 | complement activation (GO:0006956) | 3.54922453 |
| 97 | fatty acid catabolic process (GO:0009062) | 3.53185218 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.51789576 |
| 99 | triglyceride catabolic process (GO:0019433) | 3.51069629 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 3.50743535 |
| 101 | sterol homeostasis (GO:0055092) | 3.50348753 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.49807215 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49412778 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.48379652 |
| 105 | * ethanol oxidation (GO:0006069) | 3.46520458 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.45613156 |
| 107 | urate metabolic process (GO:0046415) | 3.45354890 |
| 108 | acylglycerol catabolic process (GO:0046464) | 3.37775822 |
| 109 | neutral lipid catabolic process (GO:0046461) | 3.37775822 |
| 110 | regulation of sequestering of triglyceride (GO:0010889) | 3.22798920 |
| 111 | protein activation cascade (GO:0072376) | 3.20330866 |
| 112 | diacylglycerol metabolic process (GO:0046339) | 3.10387189 |
| 113 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.04782718 |
| 114 | NADH metabolic process (GO:0006734) | 3.01322494 |
| 115 | transcytosis (GO:0045056) | 2.99440457 |
| 116 | uronic acid metabolic process (GO:0006063) | 2.94180816 |
| 117 | glucuronate metabolic process (GO:0019585) | 2.94180816 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 2.87512375 |
| 119 | * primary alcohol metabolic process (GO:0034308) | 2.85634981 |
| 120 | acute-phase response (GO:0006953) | 2.77497549 |
| 121 | regulation of sterol transport (GO:0032371) | 2.75973733 |
| 122 | regulation of cholesterol transport (GO:0032374) | 2.75973733 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 2.75567238 |
| 124 | cGMP-mediated signaling (GO:0019934) | 2.74344899 |
| 125 | response to mercury ion (GO:0046689) | 2.72505459 |
| 126 | negative regulation of blood coagulation (GO:0030195) | 2.68587484 |
| 127 | negative regulation of hemostasis (GO:1900047) | 2.68587484 |
| 128 | positive regulation of cholesterol transport (GO:0032376) | 2.59915606 |
| 129 | positive regulation of sterol transport (GO:0032373) | 2.59915606 |
| 130 | glycerolipid catabolic process (GO:0046503) | 2.56892650 |
| 131 | positive regulation of cholesterol efflux (GO:0010875) | 2.56738809 |
| 132 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.55603290 |
| 133 | regulation of triglyceride metabolic process (GO:0090207) | 2.54792427 |
| 134 | oxidative demethylation (GO:0070989) | 2.54220484 |
| 135 | negative regulation of complement activation (GO:0045916) | 2.53745279 |
| 136 | oxaloacetate metabolic process (GO:0006107) | 2.52902223 |
| 137 | phenylpropanoid metabolic process (GO:0009698) | 2.52863174 |
| 138 | fatty acid homeostasis (GO:0055089) | 2.51637388 |
| 139 | response to dietary excess (GO:0002021) | 2.50146330 |
| 140 | doxorubicin metabolic process (GO:0044598) | 2.49966494 |
| 141 | daunorubicin metabolic process (GO:0044597) | 2.49966494 |
| 142 | polyketide metabolic process (GO:0030638) | 2.49966494 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.48781075 |
| 144 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.48530404 |
| 145 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.45261425 |
| 146 | negative regulation of coagulation (GO:0050819) | 2.45169519 |
| 147 | lipoprotein transport (GO:0042953) | 2.44056088 |
| 148 | regulation of humoral immune response (GO:0002920) | 2.42339190 |
| 149 | lipid storage (GO:0019915) | 2.41463466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.48238295 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.59375741 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.95989015 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74987679 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.67335740 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.54716279 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.38079660 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.49349163 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.44640198 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.60575013 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17743589 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04114032 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5367943 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96652377 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94756258 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93102841 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.85384699 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80272250 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65066928 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65066572 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60189376 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58476020 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49824211 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45679868 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43902022 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42079496 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41136689 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40611764 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37463835 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36684384 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33478454 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31757487 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27827724 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26197671 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25636698 |
| 36 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24685219 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21648107 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21531459 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20786490 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20651726 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17616933 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16614524 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16301617 |
| 44 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14369817 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13982399 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13982399 |
| 47 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.13818827 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13459207 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12630169 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11139341 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10564906 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08502737 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08293761 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04612923 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03670437 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03000513 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01319294 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01093209 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98041085 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97540425 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97474748 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96108884 |
| 63 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94742929 |
| 64 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94325483 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93232373 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92605944 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92059820 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91666814 |
| 69 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89477547 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88935351 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86788393 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86500312 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86362179 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85808278 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85762262 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85396950 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85309486 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85164913 |
| 79 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.84925179 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84860971 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84543580 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.84123301 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.84011339 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.83150096 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82971058 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82685312 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82592161 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82554460 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82031124 |
| 90 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80491119 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80386305 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80367769 |
| 93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.79429947 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79318590 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78895677 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.78691445 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78594999 |
| 98 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78567042 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78308336 |
| 100 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78132653 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77591526 |
| 102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77449928 |
| 103 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77417301 |
| 104 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77240942 |
| 105 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76573519 |
| 106 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76102073 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74038218 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73118782 |
| 109 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73102866 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71577845 |
| 111 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.71333863 |
| 112 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71052196 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70390158 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70104136 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70054728 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.70051254 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69981967 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69681877 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69069422 |
| 120 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.68705708 |
| 121 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.68296620 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68038830 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.67884647 |
| 124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67218384 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67072068 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66389707 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65798154 |
| 128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65338489 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65099831 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64737396 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64697974 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64036032 |
| 133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.63898482 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63643753 |
| 135 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62973998 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62549785 |
| 137 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.62245959 |
| 138 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.62160155 |
| 139 | ATF3_27146783_Chip-Seq_COLON_Human | 0.61458492 |
| 140 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58462652 |
| 141 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.58278053 |
| 142 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58204817 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57170296 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57170296 |
| 145 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.57101460 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.56855844 |
| 147 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.56497808 |
| 148 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.56428272 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.55830562 |
| 150 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55773857 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55329374 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.55125324 |
| 153 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.53976771 |
| 154 | MAF_26560356_Chip-Seq_TH1_Human | 0.53196651 |
| 155 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53048561 |
| 156 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53019086 |
| 157 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52135049 |
| 158 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.51316302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.53997773 |
| 2 | MP0005360_urolithiasis | 6.90243747 |
| 3 | MP0005365_abnormal_bile_salt | 5.61869340 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.59950160 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.82427085 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.83958056 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.49059046 |
| 8 | MP0003252_abnormal_bile_duct | 3.46918704 |
| 9 | MP0009840_abnormal_foam_cell | 3.40280024 |
| 10 | MP0005083_abnormal_biliary_tract | 2.86777217 |
| 11 | MP0005332_abnormal_amino_acid | 2.70901010 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.69718933 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.40179755 |
| 14 | MP0003195_calcinosis | 2.36479075 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16178179 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.07954825 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.07170891 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.98860012 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.92706460 |
| 20 | MP0003879_abnormal_hair_cell | 1.85137501 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.76096661 |
| 22 | MP0001501_abnormal_sleep_pattern | 1.55909996 |
| 23 | MP0003868_abnormal_feces_composition | 1.55457666 |
| 24 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.53692593 |
| 25 | MP0001764_abnormal_homeostasis | 1.52230201 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.51604204 |
| 27 | MP0003186_abnormal_redox_activity | 1.46353309 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.30156023 |
| 29 | MP0005670_abnormal_white_adipose | 1.28707418 |
| 30 | MP0004043_abnormal_pH_regulation | 1.25935500 |
| 31 | MP0000598_abnormal_liver_morphology | 1.24858579 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.22759009 |
| 33 | MP0005451_abnormal_body_composition | 1.18551280 |
| 34 | MP0004130_abnormal_muscle_cell | 1.18252614 |
| 35 | MP0003011_delayed_dark_adaptation | 1.17179545 |
| 36 | MP0009764_decreased_sensitivity_to | 1.11576673 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.09089330 |
| 38 | MP0009763_increased_sensitivity_to | 1.05312768 |
| 39 | MP0008469_abnormal_protein_level | 1.03897502 |
| 40 | MP0003828_pulmonary_edema | 1.01763489 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.01110266 |
| 42 | MP0000604_amyloidosis | 1.00747671 |
| 43 | MP0005647_abnormal_sex_gland | 0.99452324 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.99242504 |
| 45 | MP0002254_reproductive_system_inflammat | 0.98086518 |
| 46 | MP0002064_seizures | 0.98039511 |
| 47 | MP0000751_myopathy | 0.96137004 |
| 48 | MP0006138_congestive_heart_failure | 0.95595945 |
| 49 | MP0005058_abnormal_lysosome_morphology | 0.95463788 |
| 50 | MP0001958_emphysema | 0.95333993 |
| 51 | MP0003633_abnormal_nervous_system | 0.93915692 |
| 52 | MP0005666_abnormal_adipose_tissue | 0.90302989 |
| 53 | MP0002971_abnormal_brown_adipose | 0.89995560 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.89551812 |
| 55 | MP0009697_abnormal_copulation | 0.89034789 |
| 56 | MP0005464_abnormal_platelet_physiology | 0.88881475 |
| 57 | MP0003436_decreased_susceptibility_to | 0.88297381 |
| 58 | MP0000920_abnormal_myelination | 0.88083632 |
| 59 | MP0003183_abnormal_peptide_metabolism | 0.85486976 |
| 60 | MP0005595_abnormal_vascular_smooth | 0.85064477 |
| 61 | MP0001756_abnormal_urination | 0.84446451 |
| 62 | MP0009745_abnormal_behavioral_response | 0.84010460 |
| 63 | MP0004270_analgesia | 0.82146899 |
| 64 | MP0001440_abnormal_grooming_behavior | 0.82065312 |
| 65 | MP0003646_muscle_fatigue | 0.81922214 |
| 66 | * MP0006036_abnormal_mitochondrial_physio | 0.81287793 |
| 67 | MP0003724_increased_susceptibility_to | 0.79584435 |
| 68 | MP0005334_abnormal_fat_pad | 0.79159315 |
| 69 | MP0006082_CNS_inflammation | 0.78911219 |
| 70 | MP0003300_gastrointestinal_ulcer | 0.77594200 |
| 71 | MP0005164_abnormal_response_to | 0.77056988 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.76589898 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.74991621 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.74966920 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.74873227 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.74232713 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.74163621 |
| 78 | MP0003959_abnormal_lean_body | 0.73976815 |
| 79 | MP0000230_abnormal_systemic_arterial | 0.73521792 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.72997292 |
| 81 | MP0005165_increased_susceptibility_to | 0.70972810 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.70055584 |
| 83 | MP0001533_abnormal_skeleton_physiology | 0.69697723 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.69635126 |
| 85 | MP0003631_nervous_system_phenotype | 0.69084284 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.68002526 |
| 87 | MP0004859_abnormal_synaptic_plasticity | 0.66007245 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.65930977 |
| 89 | MP0002133_abnormal_respiratory_system | 0.65433664 |
| 90 | MP0005388_respiratory_system_phenotype | 0.65433664 |
| 91 | MP0003075_altered_response_to | 0.63972372 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.63651345 |
| 93 | MP0005408_hypopigmentation | 0.63493011 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 0.63168909 |
| 95 | MP0005385_cardiovascular_system_phenoty | 0.63168909 |
| 96 | MP0001486_abnormal_startle_reflex | 0.62913901 |
| 97 | MP0004883_abnormal_blood_vessel | 0.62773808 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.62434389 |
| 99 | MP0001661_extended_life_span | 0.62425865 |
| 100 | MP0001853_heart_inflammation | 0.60885906 |
| 101 | MP0003690_abnormal_glial_cell | 0.60455605 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.60048933 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.59989049 |
| 104 | MP0005535_abnormal_body_temperature | 0.59644298 |
| 105 | MP0005266_abnormal_metabolism | 0.59555569 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.59056250 |
| 107 | MP0009115_abnormal_fat_cell | 0.57636819 |
| 108 | MP0009053_abnormal_anal_canal | 0.56503965 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.56354426 |
| 110 | MP0000249_abnormal_blood_vessel | 0.54385340 |
| 111 | MP0003303_peritoneal_inflammation | 0.53744381 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.52398066 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.51708507 |
| 114 | MP0005448_abnormal_energy_balance | 0.51569367 |
| 115 | MP0005166_decreased_susceptibility_to | 0.51280428 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.51163751 |
| 117 | MP0005023_abnormal_wound_healing | 0.50711644 |
| 118 | MP0002970_abnormal_white_adipose | 0.49955015 |
| 119 | MP0008873_increased_physiological_sensi | 0.49720635 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.49545206 |
| 121 | MP0003329_amyloid_beta_deposits | 0.47996720 |
| 122 | MP0002796_impaired_skin_barrier | 0.46858006 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.45186521 |
| 124 | MP0002928_abnormal_bile_duct | 0.44984879 |
| 125 | MP0002060_abnormal_skin_morphology | 0.44353346 |
| 126 | MP0000685_abnormal_immune_system | 0.44080022 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.43719691 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.43312042 |
| 129 | MP0008874_decreased_physiological_sensi | 0.42640551 |
| 130 | MP0002168_other_aberrant_phenotype | 0.42118831 |
| 131 | MP0004947_skin_inflammation | 0.42056303 |
| 132 | MP0002419_abnormal_innate_immunity | 0.41225636 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.41182278 |
| 134 | MP0005025_abnormal_response_to | 0.41057700 |
| 135 | MP0000343_altered_response_to | 0.40286943 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.40185347 |
| 137 | MP0009785_altered_susceptibility_to | 0.39720796 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.39486579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.78939575 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.53780390 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.31100927 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.01017850 |
| 5 | Xanthomatosis (HP:0000991) | 5.86574357 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.44705836 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.43089408 |
| 8 | Complement deficiency (HP:0004431) | 5.14302677 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.04147919 |
| 10 | Hyperammonemia (HP:0001987) | 4.54638305 |
| 11 | Joint hemorrhage (HP:0005261) | 4.27897909 |
| 12 | Ketosis (HP:0001946) | 4.25056945 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.22658127 |
| 14 | Hyperglycinuria (HP:0003108) | 4.21499215 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13633439 |
| 16 | Hyperglycinemia (HP:0002154) | 4.11344409 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02413016 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01328664 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.01328664 |
| 20 | Epidermoid cyst (HP:0200040) | 3.95145416 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93258127 |
| 22 | Abnormality of complement system (HP:0005339) | 3.90272186 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.87297926 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.85895411 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.74504514 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.68823017 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61958426 |
| 28 | Fat malabsorption (HP:0002630) | 3.59336939 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.55302289 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45417573 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.43222439 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40617125 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.37216708 |
| 34 | Ketoacidosis (HP:0001993) | 3.17468159 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.09913438 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06330961 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.02931215 |
| 38 | Myocardial infarction (HP:0001658) | 3.02302996 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.00353110 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.90888087 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90082376 |
| 42 | Oligomenorrhea (HP:0000876) | 2.84206047 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.79809854 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79809854 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.78692019 |
| 46 | Metabolic acidosis (HP:0001942) | 2.74974136 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.74947057 |
| 48 | Steatorrhea (HP:0002570) | 2.74679505 |
| 49 | Gout (HP:0001997) | 2.74419108 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.73696934 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68879031 |
| 52 | Spastic diplegia (HP:0001264) | 2.67754347 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.64880205 |
| 54 | Skin nodule (HP:0200036) | 2.63724621 |
| 55 | Glomerulonephritis (HP:0000099) | 2.52620092 |
| 56 | Vascular calcification (HP:0004934) | 2.52534455 |
| 57 | Esophageal varix (HP:0002040) | 2.50299671 |
| 58 | Spontaneous abortion (HP:0005268) | 2.49739226 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45229952 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45229952 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45229952 |
| 62 | Mutism (HP:0002300) | 2.43630585 |
| 63 | Lethargy (HP:0001254) | 2.43567757 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.39109401 |
| 65 | Neonatal onset (HP:0003623) | 2.36048003 |
| 66 | Mitral stenosis (HP:0001718) | 2.33783563 |
| 67 | Abnormality of the periventricular white matter (HP:0002518) | 2.32040936 |
| 68 | Malnutrition (HP:0004395) | 2.30982179 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.30334063 |
| 70 | Amyloidosis (HP:0011034) | 2.29656162 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.28932151 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.28639723 |
| 73 | Atrioventricular block (HP:0001678) | 2.27801199 |
| 74 | Late onset (HP:0003584) | 2.26887106 |
| 75 | Abnormal eating behavior (HP:0100738) | 2.26763280 |
| 76 | Cholelithiasis (HP:0001081) | 2.23913461 |
| 77 | Menorrhagia (HP:0000132) | 2.21563777 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.20962580 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.20804572 |
| 80 | Purpura (HP:0000979) | 2.20211770 |
| 81 | Gingival bleeding (HP:0000225) | 2.19048405 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.18979792 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.18979792 |
| 84 | Heart block (HP:0012722) | 2.18032170 |
| 85 | Abnormality of renin-angiotensin system (HP:0000847) | 2.17368887 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 2.17082202 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.15924809 |
| 88 | Irritability (HP:0000737) | 2.15262935 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14579661 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14579661 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14579661 |
| 92 | Pancreatitis (HP:0001733) | 2.14307082 |
| 93 | Abnormal gallbladder physiology (HP:0012438) | 2.14056198 |
| 94 | Cholecystitis (HP:0001082) | 2.14056198 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.13544833 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.13366891 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.12380481 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.11186696 |
| 99 | Vomiting (HP:0002013) | 2.10970624 |
| 100 | Thrombophlebitis (HP:0004418) | 2.09464755 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08408652 |
| 102 | Mucopolysacchariduria (HP:0008155) | 2.08408652 |
| 103 | Axonal loss (HP:0003447) | 2.08027201 |
| 104 | Acanthosis nigricans (HP:0000956) | 2.07859788 |
| 105 | Acanthocytosis (HP:0001927) | 2.07684302 |
| 106 | Retinal atrophy (HP:0001105) | 2.07398600 |
| 107 | Pigmentary retinal degeneration (HP:0001146) | 2.06965001 |
| 108 | Polycythemia (HP:0001901) | 2.05840479 |
| 109 | Abnormal atrioventricular conduction (HP:0005150) | 2.04811763 |
| 110 | Nephritis (HP:0000123) | 2.04061471 |
| 111 | Hypoglycemic seizures (HP:0002173) | 2.03931502 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.03929554 |
| 113 | Polyphagia (HP:0002591) | 2.02888515 |
| 114 | Cerebral edema (HP:0002181) | 2.02844405 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01847683 |
| 116 | Hyperactive renin-angiotensin system (HP:0000841) | 2.00906351 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.98383201 |
| 118 | Cerebral palsy (HP:0100021) | 1.97934952 |
| 119 | Brushfield spots (HP:0001088) | 1.95677791 |
| 120 | Rickets (HP:0002748) | 1.95440777 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92239499 |
| 122 | Increased purine levels (HP:0004368) | 1.88993365 |
| 123 | Hyperuricemia (HP:0002149) | 1.88993365 |
| 124 | Ventricular fibrillation (HP:0001663) | 1.88046542 |
| 125 | Proximal tubulopathy (HP:0000114) | 1.87948235 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.87231587 |
| 127 | Alkalosis (HP:0001948) | 1.87190960 |
| 128 | Nausea (HP:0002018) | 1.87040878 |
| 129 | Pulmonary embolism (HP:0002204) | 1.83645554 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83529092 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 1.83433774 |
| 132 | Myokymia (HP:0002411) | 1.83122966 |
| 133 | Opisthotonus (HP:0002179) | 1.82804740 |
| 134 | Eczematoid dermatitis (HP:0000976) | 1.82549769 |
| 135 | Bundle branch block (HP:0011710) | 1.80045141 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79113672 |
| 137 | Hyperaldosteronism (HP:0000859) | 1.79003733 |
| 138 | Metabolic alkalosis (HP:0200114) | 1.78011994 |
| 139 | Polygenic inheritance (HP:0010982) | 1.76628411 |
| 140 | Increased serum ferritin (HP:0003281) | 1.75379231 |
| 141 | Elevated hepatic transaminases (HP:0002910) | 1.75035019 |
| 142 | Increased mean platelet volume (HP:0011877) | 1.74979555 |
| 143 | Syncope (HP:0001279) | 1.72477804 |
| 144 | Potter facies (HP:0002009) | 1.71305427 |
| 145 | Facial shape deformation (HP:0011334) | 1.71305427 |
| 146 | Poikilocytosis (HP:0004447) | 1.71227059 |
| 147 | Visceral angiomatosis (HP:0100761) | 1.61494347 |
| 148 | Exercise-induced myalgia (HP:0003738) | 1.60945068 |
| 149 | Hypokalemia (HP:0002900) | 1.59881485 |
| 150 | Bronchomalacia (HP:0002780) | 1.59518081 |
| 151 | Stroke (HP:0001297) | 1.58101481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.84887507 |
| 2 | ERN1 | 4.84648437 |
| 3 | SIK1 | 3.86811860 |
| 4 | TRIB3 | 3.83234074 |
| 5 | FGFR4 | 3.35907804 |
| 6 | PKN2 | 3.31421844 |
| 7 | TAOK3 | 2.35619511 |
| 8 | FLT3 | 2.32210982 |
| 9 | MST1R | 2.13506446 |
| 10 | NTRK3 | 1.96106244 |
| 11 | ACVR1B | 1.87681496 |
| 12 | PTK6 | 1.81297640 |
| 13 | RIPK4 | 1.81160247 |
| 14 | MAP2K3 | 1.80618451 |
| 15 | EPHA4 | 1.74404238 |
| 16 | TGFBR2 | 1.66576552 |
| 17 | TYK2 | 1.65543447 |
| 18 | RIPK1 | 1.64624262 |
| 19 | CAMK1D | 1.50948688 |
| 20 | MAPK11 | 1.50938761 |
| 21 | DDR2 | 1.48247225 |
| 22 | EPHB1 | 1.47152474 |
| 23 | EEF2K | 1.39431912 |
| 24 | ERBB4 | 1.37581537 |
| 25 | TIE1 | 1.36736461 |
| 26 | TBK1 | 1.36358522 |
| 27 | MAP3K10 | 1.35678939 |
| 28 | INSRR | 1.34417012 |
| 29 | KDR | 1.31919503 |
| 30 | MARK1 | 1.30489691 |
| 31 | GRK6 | 1.29567583 |
| 32 | OBSCN | 1.28899875 |
| 33 | EPHB2 | 1.28173001 |
| 34 | PIK3CG | 1.27781702 |
| 35 | CAMK1 | 1.26578826 |
| 36 | PRPF4B | 1.26523437 |
| 37 | LRRK2 | 1.22903958 |
| 38 | NEK9 | 1.22632331 |
| 39 | TTN | 1.18117016 |
| 40 | PHKG1 | 1.17017784 |
| 41 | PHKG2 | 1.17017784 |
| 42 | CAMKK1 | 1.15765329 |
| 43 | MAP3K13 | 1.12766996 |
| 44 | MAP3K3 | 1.11341984 |
| 45 | KIT | 1.11280587 |
| 46 | CAMKK2 | 1.10795490 |
| 47 | MAP2K4 | 1.10739907 |
| 48 | MAP3K7 | 1.10110493 |
| 49 | CSF1R | 1.08810074 |
| 50 | LATS1 | 1.06660637 |
| 51 | MAP3K11 | 1.06531341 |
| 52 | JAK2 | 1.06439223 |
| 53 | MAP4K1 | 1.04222874 |
| 54 | PRKAA2 | 1.02237757 |
| 55 | CDC42BPA | 1.02117572 |
| 56 | GRK5 | 1.01666807 |
| 57 | ABL2 | 0.99406934 |
| 58 | MARK2 | 0.95995060 |
| 59 | SGK494 | 0.94141475 |
| 60 | SGK223 | 0.94141475 |
| 61 | TNK2 | 0.93990431 |
| 62 | FES | 0.93317965 |
| 63 | CSK | 0.91510082 |
| 64 | JAK1 | 0.90876635 |
| 65 | CDK6 | 0.89161243 |
| 66 | PIK3CA | 0.87632388 |
| 67 | PAK6 | 0.84918010 |
| 68 | SGK2 | 0.82865748 |
| 69 | MAPKAPK3 | 0.80964082 |
| 70 | MAPK4 | 0.79186345 |
| 71 | MET | 0.78591706 |
| 72 | OXSR1 | 0.78283816 |
| 73 | DAPK2 | 0.77740430 |
| 74 | TESK1 | 0.77217170 |
| 75 | PKN1 | 0.75557205 |
| 76 | ADRBK2 | 0.75053404 |
| 77 | CAMK1G | 0.73843990 |
| 78 | MYLK | 0.73833755 |
| 79 | FER | 0.72531756 |
| 80 | MAPK7 | 0.72145971 |
| 81 | GRK7 | 0.71827459 |
| 82 | BTK | 0.71787167 |
| 83 | FRK | 0.71278525 |
| 84 | DYRK1B | 0.69319844 |
| 85 | CAMK4 | 0.69115116 |
| 86 | ZAP70 | 0.68401104 |
| 87 | NTRK2 | 0.67660464 |
| 88 | PDK3 | 0.67417752 |
| 89 | PDK4 | 0.67417752 |
| 90 | PDK2 | 0.66959945 |
| 91 | CAMK2G | 0.66621752 |
| 92 | IRAK3 | 0.66399063 |
| 93 | KSR2 | 0.66206986 |
| 94 | PRKD1 | 0.64517792 |
| 95 | MAPK12 | 0.64114892 |
| 96 | BLK | 0.63830556 |
| 97 | GRK1 | 0.63641966 |
| 98 | ADRBK1 | 0.63473944 |
| 99 | ARAF | 0.63047538 |
| 100 | TGFBR1 | 0.62964941 |
| 101 | CASK | 0.61611539 |
| 102 | CAMK2B | 0.61237434 |
| 103 | PTK2 | 0.61072438 |
| 104 | FGFR2 | 0.60295872 |
| 105 | PRKG1 | 0.60172941 |
| 106 | STK38 | 0.60008483 |
| 107 | PAK4 | 0.59502187 |
| 108 | CDK5 | 0.59241455 |
| 109 | PDGFRA | 0.58164096 |
| 110 | GSK3A | 0.56817632 |
| 111 | STK10 | 0.56792555 |
| 112 | CDK4 | 0.56562970 |
| 113 | MAP3K2 | 0.55913292 |
| 114 | CAMK2A | 0.55405578 |
| 115 | PDPK1 | 0.54503640 |
| 116 | BMX | 0.53456934 |
| 117 | SGK1 | 0.53178557 |
| 118 | MATK | 0.53131481 |
| 119 | PRKACA | 0.52485858 |
| 120 | MTOR | 0.52052177 |
| 121 | PINK1 | 0.51604466 |
| 122 | ERBB2 | 0.51295728 |
| 123 | MAP2K2 | 0.50383060 |
| 124 | FGFR3 | 0.50341023 |
| 125 | IKBKE | 0.49506739 |
| 126 | MAP2K6 | 0.49490383 |
| 127 | PRKACG | 0.48704019 |
| 128 | EPHA3 | 0.48213937 |
| 129 | NEK1 | 0.47717319 |
| 130 | PRKAA1 | 0.46429200 |
| 131 | RET | 0.45566995 |
| 132 | MAP2K1 | 0.45031788 |
| 133 | PRKCZ | 0.42649022 |
| 134 | JAK3 | 0.42248487 |
| 135 | NME2 | 0.41528201 |
| 136 | ICK | 0.40193158 |
| 137 | PRKG2 | 0.39984451 |
| 138 | MAP3K6 | 0.38464974 |
| 139 | MAPK15 | 0.35752124 |
| 140 | EGFR | 0.35663802 |
| 141 | EPHA2 | 0.34076441 |
| 142 | MAP3K1 | 0.33756176 |
| 143 | LMTK2 | 0.33163380 |
| 144 | PDK1 | 0.33054575 |
| 145 | PAK2 | 0.32760951 |
| 146 | IGF1R | 0.32445423 |
| 147 | MAP3K14 | 0.31633565 |
| 148 | SGK3 | 0.30473321 |
| 149 | MAP3K5 | 0.29035136 |
| 150 | MAP3K8 | 0.26998455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18652542 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43748137 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20461975 |
| 4 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15431290 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91288192 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66764205 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63623998 |
| 8 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.63334679 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59220689 |
| 10 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56100736 |
| 11 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50732846 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39729018 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21280928 |
| 14 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18710187 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10877992 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09712587 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08273402 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07064462 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06103279 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01998780 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90625165 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88565927 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88494054 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87471200 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73967005 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73831404 |
| 27 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64207715 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59532538 |
| 29 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.58883587 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58344356 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55588178 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54611933 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48223339 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.48103518 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42164132 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39081874 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38770041 |
| 38 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37887111 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32596902 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32515000 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32393932 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28438336 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26479359 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24894333 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20772343 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19845218 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.19668189 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17448554 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08816143 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08078002 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99809281 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97667119 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92905450 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87835961 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.87407987 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84523849 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84079068 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82852728 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80585149 |
| 60 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79865680 |
| 61 | * Lysine degradation_Homo sapiens_hsa00310 | 0.78600343 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78468397 |
| 63 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77380408 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73483760 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71412439 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70484108 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70288616 |
| 68 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69432603 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.54855547 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53926051 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.52838242 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50869844 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49714986 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42994849 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42622853 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.41365925 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41028683 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40813288 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38136500 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36774459 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35862726 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.35340517 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32640938 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32076148 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.31676187 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31228516 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.29792603 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29551110 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28994831 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.28618857 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28508208 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28436895 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.27842106 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.26346407 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24624408 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23284907 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.22823006 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22627051 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20275883 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.20253268 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16643645 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16038135 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10656167 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09353761 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09344488 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08732478 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02666595 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02514696 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02506256 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02501110 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.00735622 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1667283 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1630814 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1622992 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1482155 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1451622 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1350335 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1190924 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1125652 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1010882 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -0.0801384 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | -0.0656113 |
| 123 | Pertussis_Homo sapiens_hsa05133 | -0.0642637 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | -0.0587850 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0485972 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0443473 |

